Kite Pharma KITE announced that it has entered into a strategic partnership with Daiichi Sankyo to develop and commercialize axicabtagene ciloleucel KTE C19 in Japan In another press release Kite Pharma declared that it has formed a joint venture Fosun Pharma Kite Biotechnology Co